Infrared Low-Level Laser Therapy (Photobiomodulation Therapy) before Intense Progressive Running Test of High-Level Soccer Players: Effects on Functional, Muscle Damage, Inflammatory, and Oxidative Stress Markers-A Randomized Controlled Trial.
Shaiane Silva TomazoniCaroline Dos Santos Monteiro MachadoThiago de MarchiHeliodora Leão CasalechiJan Magnus BjordalPaulo de Tarso Camillo de CarvalhoErnesto Cesar Pinto Leal-JuniorPublished in: Oxidative medicine and cellular longevity (2019)
The effects of preexercise photobiomodulation therapy (PBMT) to enhance performance, accelerate recovery, and attenuate exercise-induced oxidative stress were still not fully investigated, especially in high-level athletes. The aim of this study was to evaluate the effects of PBMT (using infrared low-level laser therapy) applied before a progressive running test on functional aspects, muscle damage, and inflammatory and oxidative stress markers in high-level soccer players. A randomized, triple-blind, placebo-controlled crossover trial was performed. Twenty-two high-level male soccer players from the same team were recruited and treated with active PBMT and placebo. The order of interventions was randomized. Immediately after the application of active PBMT or placebo, the volunteers performed a standardized high-intensity progressive running test (ergospirometry test) until exhaustion. We analyzed rates of oxygen uptake (VO2 max), time until exhaustion, and aerobic and anaerobic threshold during the intense progressive running test. Creatine kinase (CK) and lactate dehydrogenase (LDH) activities, levels of interleukin-1β (IL-1-β), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α), levels of thiobarbituric acid (TBARS) and carbonylated proteins, and catalase (CAT) and superoxide dismutase (SOD) activities were measured before and five minutes after the end of the test. PBMT increased the VO2 max (both relative and absolute values-p < 0.0467 and p < 0.0013, respectively), time until exhaustion (p < 0.0043), time (p < 0.0007) and volume (p < 0.0355) in which anaerobic threshold happened, and volume in which aerobic threshold happened (p < 0.0068). Moreover, PBMT decreased CK (p < 0.0001) and LDH (p < 0.0001) activities. Regarding the cytokines, PBMT decreased only IL-6 (p < 0.0001). Finally, PBMT decreased TBARS (p < 0.0001) and carbonylated protein levels (p < 0.01) and increased SOD (p < 0.0001)and CAT (p < 0.0001) activities. The findings of this study demonstrate that preexercise PBMT acts on different functional aspects and biochemical markers. Moreover, preexercise PBMT seems to play an important antioxidant effect, decreasing exercise-induced oxidative stress and consequently enhancing athletic performance and improving postexercise recovery. This trial is registered with Clinicaltrials.gov NCT03803956.
Keyphrases
- high intensity
- oxidative stress
- placebo controlled
- phase iii
- double blind
- resistance training
- multiple sclerosis
- phase ii
- clinical trial
- open label
- study protocol
- hydrogen peroxide
- rheumatoid arthritis
- wastewater treatment
- physical activity
- dna damage
- ischemia reperfusion injury
- diabetic rats
- microbial community
- palliative care
- stem cells
- radiation therapy
- binding protein
- induced apoptosis
- protein kinase
- squamous cell carcinoma
- bone marrow
- amyotrophic lateral sclerosis
- mass spectrometry
- protein protein
- wound healing
- nitric oxide
- high resolution
- cell therapy
- heavy metals
- sewage sludge
- mesenchymal stem cells
- endoplasmic reticulum stress